Originating 80–100 explorations per year and founding ProtoCos→NewCos→GrowthCos, as principal founder building bioplatforms with proprietary discovery engines and in‑house drug development unit partnered with Pfizer and Novo Nordisk.
Targets hard, capital‑intensive sustainability technologies other VCs avoid, bridging solutions from developed markets into China and developing countries (energy, food, health, environment) to build traction back into developed markets.
NY headquarters plus offices in Accra, Cairo and Nairobi combine global capital-market access with local operator proximity; ex-Bridgewater/Morgan Stanley founders and repeat backer of Africa's B2B e-commerce leaders.
Women-led VC systematically backs clinically rigorous, behaviorally grounded wellbeing startups tackling stigmatized areas—alcohol use disorder, menopause, mental health—using stigma as an investing edge and insisting on consumer-grade UX.
Seed-stage fund founded by Ramtin Naimi whose boom-bust-resurgence background runs an institutionalized super-angel network that orchestrates targeted introductions to top multi-stage funds, boosting Series A graduation.
Seed-stage investor in for-profit startups building new products or business models to expand high-quality financial services for underserved populations, offering support to founders.
A climate-focused agrifood fund evolved from corporate-backed to institutional VC, offering founders rare food-policy and regulatory expertise through partner Sam Kass.